MarketPeel
Insider Trading Intelligence
ED

Eric Joseph Daniels

KPRX
CHIEF DEVELOPMENT OFFICER · KIORA PHARMACEUTICALS INC · CIK 0001892943
FILING MIX · LIFETIME90%/10%
BUYS
18
SELLS
2
TOTAL VALUE
$9.9K
COMPANIES
2
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
51,741
AVG SELL PX
$1.96
TRADE KIND
SHOWING 20 / 20
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Eric Joseph Daniels, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-30.60%+0.64%-31.24%-31.24%
14d1+0.00%-21.64%+0.59%-22.23%-22.23%
30d1+0.00%-23.13%+3.79%-26.92%-26.92%
60d1+0.00%-41.23%+0.19%-41.42%-41.42%
90d1+0.00%-32.46%+3.34%-35.80%-35.80%
180d1+0.00%-34.52%+12.62%-47.14%-47.14%
1y1+0.00%-43.66%+11.39%-55.05%-55.05%
2y1+0.00%-51.81%+36.66%-88.47%-88.47%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KPRX · 31,741 shares · as of Apr 1, 2026
031,25062,50093,750125,00020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 18 buys / 2 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Apr 20, 2026Apr 22, 2026View →
PSTV
PLUS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00020,000Apr 20, 2026Apr 22, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
SALE
Chief Development Officer
929$1.95$1.8K31,741Apr 1, 2026Apr 2, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,53332,670Mar 6, 2026Mar 10, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
13,06713,067Mar 6, 2026Mar 10, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
SALE
Chief Development Officer
238$2.02$48126,137Mar 3, 2026Mar 6, 2026View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,54315,543Apr 1, 2025Apr 2, 2025View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,77226,375Apr 1, 2025Apr 2, 2025View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,71014,710Jul 1, 2024Jul 3, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,35518,577Jul 1, 2024Jul 3, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASE
Chief Development Officer
1,431$5.29$7.6K11,222Jun 14, 2024Jun 14, 2024View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
125,000125,000Sep 29, 2023Oct 3, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
62,50088,338Sep 29, 2023Oct 3, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,40010,400Mar 3, 2023Mar 8, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,60025,838Mar 3, 2023Mar 8, 2023View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,00010,238Oct 21, 2022Oct 25, 2022View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,00015,000Oct 21, 2022Oct 25, 2022View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,00025,000Feb 1, 2022Feb 3, 2022View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
50,00050,000Oct 21, 2021Nov 10, 2021View →
KPRX
KIORA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
9,5209,520Oct 21, 2021Nov 22, 2021View →
Other insiders · KPRX
Loading peer insiders…
About this filer
CIK 0001892943
ROLE
Chief Development Officer
PRIMARY
KPRX
COMPANIES
2
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001892943DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback